White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

Journal of the Neurological Sciences

Volumn 282, Issue 1-2, 2009, Pages 28-33

  Varga, Andrew W ^a   Johnson, Glyn ^a   Babb, James S ^a   Herbert, Joseph ^a   Grossman, Robert I ^a   Inglese, Matilde ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Clinically isolated syndrome; Conventional MRI; Dynamic susceptibility contrast perfusion MRI; Normal appearing gray matter; Normal appearing white matter; Relapsing remitting MS

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN CORTEX; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HEMODYNAMICS; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; WHITE MATTER;

ADULT; AGE OF ONSET; BLOOD FLOW VELOCITY; BLOOD VOLUME; BRAIN; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; REGIONAL BLOOD FLOW; TIME FACTORS; YOUNG ADULT;

EID: 67349167121     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.036     Document Type: Article

References (45)

1. Hauser S.L. Multiple sclerosis and other demyelinating diseases. In: Isselbacher K.J.W.J., Martin J.B., Fauci A.S., and Kasper D.L. (Eds). Harrison's principles of internal medicine (1994), McGraw-Hill, New York 2287-2295
2. Bjartmar C., and Trapp B.D. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox Res 5 1-2 (2003) 157-164
3. Dalton C.M., Chard D.T., Davies G.R., Miszkiel K.A., Altmann D.R., Fernando K., et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127 Pt 5 (2004) 1101-1107 Electronic publication 2004 Mar 1103
4. Dawson J. The histology of disseminated sclerosis. Trans R Soc Edinb 108 (1916) 397-399
5. Putnam T. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 209 (1933) 786-790
6. Adams C.W., Poston R.N., and Buk S.J. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 92 2-3 (1989) 291-306
7. Tanaka R., Iwasaki Y., and Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 81 3 (1975) 467-478
8. Putnam T. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 32 (1935) 1298-1321
9. Adams C.W., Poston R.N., Buk S.J., Sidhu Y.S., and Vipond H. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 69 3 (1985) 269-283
10. Wakefield A.J., More L.J., Difford J., and McLaughlin J.E. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47 2 (1994) 129-133
11. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., and Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61 10 (2002) 914-925
12. Su J.J., Osoegawa M., Matsuoka T., Minohara M., Tanaka M., Ishizu T., et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 243 1-2 (2006) 21-30
13. Rashid W., Parkes L.M., Ingle G.T., Chard D.T., Toosy A.T., Altmann D.R., et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 75 9 (2004) 1288-1293
14. Wuerfel J., Bellmann-Strobl J., Brunecker P., Aktas O., McFarland H., Villringer A., et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 127 Pt 1 (2004) 111-119
15. Adhya S., Johnson G., Herbert J., Jaggi H., Babb J.S., Grossman R.I., et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33 4 (2006) 1029-1035 Electronic publication 2006 Sep 1022
16. Inglese M., Park S.J., Johnson G., Babb J.S., Miles L., Jaggi H., et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 64 2 (2007) 196-202
17. Andeweg J. The anatomy of collateral venous flow from the brain and its value in aetiological interpretation of intracranial pathology. Neuroradiology 38 7 (1996) 621-628
18. White E., and Greitz T. Subependymal venous filling sequence at cerebral angiography. Influence of grey and white matter distribution. Acta Radiol Diagn (Stockh) 13 1 (1972) 272-285
19. Herzog H., Seitz R.J., Tellmann L., Rota Kops E., Julicher F., Schlaug G., et al. Quantitation of regional cerebral blood flow with 15O-butanol and positron emission tomography in humans. J Cereb Blood Flow Metab 16 4 (1996) 645-649
20. Helenius J., Perkio J., Soinne L., Ostergaard L., Carano R.A., Salonen O., et al. Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 44 5 (2003) 538-546
21. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 1 (2001) 121-127
22. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 11 (1983) 1444-1452
23. Rosen B.R., Belliveau J.W., Buchbinder B.R., McKinstry R.C., Porkka L.M., Kennedy D.N., et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 19 2 (1991) 285-292
24. Rempp K.A., Brix G., Wenz F., Becker C.R., Guckel F., and Lorenz W.J. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193 3 (1994) 637-641
25. Carroll T.J., Rowley H.A., and Haughton V.M. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 227 2 (2003) 593-600
26. Wetzel S.G., Cha S., Johnson G., Lee P., Law M., Kasow D.L., et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 224 3 (2002) 797-803
27. Bermel R.A., Sharma J., Tjoa C.W., Puli S.R., and Bakshi R. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 208 1-2 (2003) 57-65
28. Law M., Saindane A.M., Ge Y., Babb J.S., Johnson G., Mannon L.J., et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231 3 (2004) 645-652
29. Haselhorst R., Kappos L., Bilecen D., Scheffler K., Mori D., Radu E.W., et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging 11 5 (2000) 495-505
30. Ge Y., Law M., Johnson G., Herbert J., Babb J.S., Mannon L.J., et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol 26 6 (2005) 1539-1547
31. Miller D., Barkhof F., Montalban X., Thompson A., and Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 4 6 (2005) 341-348
32. Iannucci G., Tortorella C., Rovaris M., Sormani M.P., Comi G., and Filippi M. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. Am JNeuroradiol 21 6 (2000) 1034-1038
33. Brex P.A., Leary S.M., Plant G.T., Thompson A.J., and Miller D.H. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. Am J Neuroradiol 22 5 (2001) 947-951
34. Gallo A., Rovaris M., Riva R., Ghezzi A., Benedetti B., Martinelli V., et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 62 5 (2005) 803-808
35. Filippi M., Bozzali M., Rovaris M., Gonen O., Kesavadas C., Ghezzi A., et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 Pt 2 (2003) 433-437
36. Fernando K.T., McLean M.A., Chard D.T., MacManus D.G., Dalton C.M., Miszkiel K.A., et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127 Pt 6 (2004) 1361-1369
37. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177 2 (2000) 95-103
38. Kalman B., and Leist T.P. A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med 3 3 (2003) 147-158
39. Heales S.J., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., and Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410 2 (1999) 215-228
40. De Keyser J., Steen C., Mostert J.P., and Koch M.W. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 28 10 (2008) 1645-1651 Electronic publication 2008 Jul 1642
41. Mulligan S.J., and MacVicar B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431 7005 (2004) 195-199
42. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13 4 (2003) 554-573
43. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 206 2 (2003) 187-191
44. Semenza G.L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106 7 (2000) 809-812
45. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55 4 (2004) 458-468